miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies.

Iris Garrido-CanoAnna Adam-ArtiguesAna LameirinhasJuan F BlandezVicente Candela-NogueraFederico RojoSandra ZazoJuan Madoz-GúrpideAna LluchBegoña BermejoFelix SancenónJuan Miguel CejalvoRamón Martínez-MáñezPilar Eroles

Published in: Cancer communications (London, England) (2022)

Keyphrases

small molecule
drug delivery
case control
high throughput
cancer therapy
cancer stem cells
single cell